FDA issued a Warning Letter to PharmScript, LLC on 8/23/2017 as a result of this inspection.
FDA investigators audited the PharmScript - Somerset, NJ, United States facility and issued 7 inspectional observations (via FDA 483) on 24 Oct 2016.
Add To Cart
- Category: Human Drugs
- Number of Observations: 7
- Inspection end: 24 Oct 2016
- Location: Somerset, United States
- FEI: 3012837733